GO:0002645 positive regulation of tolerance induction: Immune Tolerance Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0002645 (positive regulation of tolerance induction) describes any biological process that activates or increases the frequency, rate, or extent of tolerance induction, a cornerstone of immune self-tolerance and transplantation tolerance [1, 5, 7].
• Key molecular players include co-inhibitory receptors such as PD-1, CTLA-4, LAG-3, and TIGIT, which form a transcriptional module that restrains T cell activation and promotes tolerance.
• Tissue-specific antigen-presenting cells, including liver sinusoidal endothelial cells, ocular cells, and DC-SIGN+ macrophages, actively induce tolerance and prevent autoimmunity [5, 6, 7].
• Thymic mimetic cells and regulatory T cells are central to central and peripheral tolerance induction, and their dysfunction is linked to autoimmunity and pregnancy complications [3, 4].
• Retinoic acid and its signaling pathways enhance tolerance induction by modulating dendritic cell and T cell function, offering therapeutic avenues for immune disorders.
• CRISPR-based knockout, knock-in, and overexpression models are essential to dissect the causal roles of specific genes in positive regulation of tolerance induction [1, 5, 7].
Description
Positive regulation of tolerance induction (GO:0002645) is a biological process that encompasses any mechanism which activates or increases the frequency, rate, or extent of tolerance induction. Tolerance induction itself is the process by which the immune system becomes non-responsive to a specific antigen, a critical safeguard against autoimmunity and a major goal in transplantation and allergy treatment [5, 6, 7]. This GO term captures the upstream signals, cellular interactions, and molecular circuits that actively promote tolerance rather than merely permitting its default state. Understanding this process is essential for researchers aiming to manipulate immune responses in autoimmune diseases, cancer immunotherapy, and organ transplantation [1, 3, 7]. The regulation of tolerance induction involves a complex interplay between antigen-presenting cells, T cell co-inhibitory receptors, and soluble mediators such as retinoic acid [1, 8]. For example, the co-inhibitory gene module in T cells, including PD-1, CTLA-4, LAG-3, and TIGIT, is transcriptionally regulated to enforce tolerance and limit immunopathology. Similarly, liver sinusoidal endothelial cells dynamically regulate CD8 T cell tolerance induction, highlighting the tissue-specific nature of this process. Ocular immune responses also rely on active tolerance induction to maintain immune privilege and prevent inflammatory damage. Thus, GO:0002645 provides a framework to study how positive regulators—genes, pathways, and cellular contexts—enhance tolerance, with direct implications for therapeutic intervention.
positive regulation of tolerance induction At A Glance
| GO ID | GO:0002645 |
|---|---|
| GO term | positive regulation of tolerance induction |
| Ontology | biological_process |
| Synonym | activation of tolerance induction; stimulation of tolerance induction; up regulation of tolerance induction; up-regulation of tolerance induction; upregulation of tolerance induction |
| Major function | Activates or increases the frequency, rate, or extent of tolerance induction, promoting immune non-responsiveness to antigens [1, 5, 7]. |
| Key cellular players | T cells, dendritic cells, macrophages, liver sinusoidal endothelial cells, thymic mimetic cells [1, 4, 5, 7]. |
| Key molecular mediators | Co-inhibitory receptors (PD-1, CTLA-4, LAG-3, TIGIT), retinoic acid, cytokines [1, 8]. |
| Physiological contexts | Self-tolerance, transplantation tolerance, ocular immune privilege, pregnancy [3, 6, 7]. |
| Disease relevance | Autoimmunity, transplant rejection, cancer immune evasion, pregnancy complications [1, 3, 7]. |
What Is GO:0002645?
According to the Gene Ontology, GO:0002645 (positive regulation of tolerance induction) is defined as any process that activates or increases the frequency, rate, or extent of tolerance induction. This means it covers molecular and cellular events that upregulate the establishment of immune non-responsiveness to antigens, including self-antigens and alloantigens. It is a biological process that sits downstream of antigen recognition and involves active signaling, transcriptional reprogramming, and cell-cell communication that favor tolerance over immunity [1, 5, 7].
Why Is positive regulation of tolerance induction Important in Cell Biology?
Positive regulation of tolerance induction is fundamental to immune homeostasis and prevents destructive immune responses against self-tissues. Its dysregulation contributes to autoimmune diseases, transplant rejection, and pregnancy loss, while its overactivation can hinder anti-tumor immunity [1, 3, 7]. Understanding the positive regulators of tolerance induction offers opportunities to develop therapies that either boost tolerance (for autoimmunity and transplantation) or break tolerance (for cancer immunotherapy) [1, 7].
• Prevents autoimmunity by promoting non-responsiveness to self-antigens [1, 4].
• Facilitates transplantation tolerance, reducing the need for lifelong immunosuppression.
• Maintains immune privilege in tissues such as the eye, preventing inflammatory damage.
• Supports successful pregnancy by regulating maternal-fetal immune tolerance.
• Limits immunopathology during chronic infections by restraining excessive T cell activation [1, 5].
• Is a mechanism of tumor immune evasion, making it a target for cancer immunotherapy.
• Involves co-inhibitory receptors that are targets of checkpoint blockade drugs.
• Can be modulated by retinoic acid, offering dietary and pharmacological intervention points.
• Thymic mimetic cells are critical for central tolerance induction, and their dysfunction leads to autoimmunity.
• Tissue-specific antigen-presenting cells, such as liver sinusoidal endothelial cells, actively induce tolerance.
What Happens During positive regulation of tolerance induction?
Antigen recognition and co-inhibitory signaling
In simple terms: When T cells recognize antigens, co-inhibitory receptors act like brakes to prevent overreaction and promote tolerance.
T cell tolerance induction is positively regulated by co-inhibitory receptors such as PD-1, CTLA-4, LAG-3, and TIGIT, which are part of a transcriptional module that restrains T cell activation. These receptors are upregulated upon repeated antigen exposure and engage ligands on antigen-presenting cells to deliver inhibitory signals, thereby increasing the threshold for activation and promoting tolerance. The co-inhibitory gene module is regulated by transcription factors including NFAT, IRF4, and BATF, which coordinate the expression of multiple checkpoint molecules to enforce tolerance.
Tissue-specific antigen-presenting cells
In simple terms: Certain cells in the liver, eye, and other tissues specialize in teaching the immune system to tolerate antigens.
Liver sinusoidal endothelial cells (LSECs) dynamically regulate CD8 T cell tolerance induction by presenting antigens in a tolerogenic context, leading to T cell dysfunction and deletion. In the eye, ocular immune responses are regulated by local antigen-presenting cells that promote tolerance and maintain immune privilege. DC-SIGN+ macrophages control the induction of transplantation tolerance by modulating T cell responses and expanding regulatory T cells. These tissue-specific APCs create a tolerogenic microenvironment that positively regulates tolerance induction.
Thymic selection and central tolerance
In simple terms: In the thymus, specialized cells help eliminate or reprogram T cells that react to self, establishing central tolerance.
Thymic mimetic cells, which express peripheral tissue antigens, function beyond self-tolerance by shaping the T cell repertoire and promoting tolerance to a wide range of self-antigens. These cells are essential for negative selection and the generation of regulatory T cells, and their dysfunction is associated with autoimmunity. The positive regulation of tolerance induction in the thymus involves AIRE and other transcription factors that drive the expression of tissue-restricted antigens, enabling the deletion of autoreactive T cells.
Role of retinoic acid and soluble mediators
In simple terms: Vitamin A derivatives like retinoic acid can push the immune system toward tolerance.
Retinoic acid, a metabolite of vitamin A, plays a critical role in the induction of immune tolerance by promoting the generation of regulatory T cells and modulating dendritic cell function. It enhances TGF-beta-dependent differentiation of Foxp3+ regulatory T cells and inhibits the differentiation of pro-inflammatory Th17 cells, thereby positively regulating tolerance induction. Other soluble mediators, including IL-10 and TGF-beta, also contribute to the tolerogenic milieu that supports tolerance induction.
Regulatory T cell expansion and function
In simple terms: Regulatory T cells are the immune system's peacekeepers, and their expansion is a key way tolerance is boosted.
Regulatory KIR+CD8+ T cells are elevated during human pregnancy and are thought to contribute to maternal-fetal tolerance. These cells, along with classical CD4+ Foxp3+ regulatory T cells, actively suppress effector T cell responses and promote tolerance induction [3, 7]. The positive regulation of tolerance induction often involves the expansion and activation of these regulatory populations, which can be driven by tolerogenic dendritic cells and cytokines.
Key Genes Involved in GO:0002645 positive regulation of tolerance induction
The following genes and proteins are key players in the positive regulation of tolerance induction, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PDCD1 (PD-1) | Co-inhibitory receptor that restrains T cell activation and promotes tolerance. | Target for cancer immunotherapy and autoimmune disease research. |
| CTLA4 | Co-inhibitory receptor that competes with CD28 for ligands and enforces tolerance. | Clinically targeted by abatacept for autoimmune diseases. |
| LAG3 | Co-inhibitory receptor that negatively regulates T cell function and promotes tolerance. | Emerging target in cancer immunotherapy. |
| TIGIT | Co-inhibitory receptor that inhibits T cell and NK cell responses, promoting tolerance. | Target for cancer immunotherapy and autoimmune research. |
| FOXP3 | Master transcription factor for regulatory T cells, essential for tolerance induction [3, 7]. | Central to studies of autoimmunity and transplantation tolerance [3, 7]. |
| Aire | Transcription factor driving thymic expression of tissue-restricted antigens for central tolerance. | Mutations cause autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED). |
| TGFB1 | Cytokine that promotes regulatory T cell differentiation and tolerance induction [7, 8]. | Therapeutic target for inducing tolerance in transplantation. |
| IL10 | Anti-inflammatory cytokine that suppresses effector T cells and promotes tolerance. | Biomarker and therapeutic agent in inflammatory diseases. |
| CD209 (DC-SIGN) | C-type lectin receptor on macrophages that mediates tolerogenic signaling. | Target for modulating transplantation tolerance. |
| KIR2DL1/2/3 | Inhibitory receptors on NK cells and T cells that regulate tolerance. | Studied in pregnancy and autoimmune contexts. |
| RARA | Retinoic acid receptor alpha, mediates retinoic acid signaling for tolerance. | Target for modulating immune responses via vitamin A metabolites. |
| RARB | Retinoic acid receptor beta, involved in tolerance induction. | Potential therapeutic target in autoimmune diseases. |
| NFAT | Transcription factor that regulates co-inhibitory gene expression. | Central to T cell exhaustion and tolerance programs. |
| IRF4 | Transcription factor that cooperates with NFAT to drive co-inhibitory module. | Modulates T cell differentiation and tolerance. |
| BATF | Transcription factor that regulates co-inhibitory receptor expression. | Involved in T cell exhaustion and tolerance. |
| CD8A | Marker of cytotoxic T cells, some of which acquire regulatory function. | Studied in pregnancy and transplantation tolerance. |
| CD4 | Marker of helper T cells, including regulatory T cells. | Central to tolerance induction studies. |
| ITGAX (CD11c) | Integrin on dendritic cells and macrophages, involved in antigen presentation. | Used to identify tolerogenic APCs. |
How Is positive regulation of tolerance induction Regulated?
The positive regulation of tolerance induction is controlled by a network of transcription factors, cytokines, and metabolic signals. The co-inhibitory gene module in T cells is transcriptionally regulated by NFAT, IRF4, and BATF, which coordinate the expression of PD-1, CTLA-4, LAG-3, and TIGIT to enforce tolerance. Retinoic acid signaling through RAR/RXR heterodimers enhances regulatory T cell differentiation and suppresses pro-inflammatory pathways. In the thymus, AIRE and other transcription factors drive the expression of tissue-restricted antigens, promoting central tolerance. Tissue-specific factors, such as those in liver sinusoidal endothelial cells, dynamically regulate CD8 T cell tolerance induction. Additionally, DC-SIGN+ macrophages modulate transplantation tolerance through interactions with T cells. These regulatory layers ensure that tolerance induction is appropriately activated in contexts such as self-antigen encounter, pregnancy, and transplantation [3, 7].
positive regulation of tolerance induction and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| AIRE | Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) | Aire knockout mouse; thymic epithelial cell cultures |
| PDCD1 | Autoimmunity and cancer immune evasion | Pdcd1 knockout mouse; tumor models |
| CTLA4 | Autoimmune lymphoproliferative syndrome and cancer | Ctla4 knockout mouse; checkpoint blockade models |
| FOXP3 | IPEX syndrome and autoimmunity [3, 7] | Foxp3 knockout mouse; regulatory T cell assays [3, 7] |
| KIR2DL1/2/3 | Pregnancy complications and autoimmunity | Humanized mouse models; NK cell assays |
Autoimmune diseases
Defects in positive regulation of tolerance induction can lead to autoimmunity. For example, mutations in AIRE cause APECED, an autoimmune polyendocrine syndrome, due to impaired central tolerance. Dysregulation of co-inhibitory receptors such as PD-1 and CTLA-4 is associated with autoimmune conditions, and checkpoint blockade in cancer can induce autoimmune adverse events. Enhancing tolerance induction is a therapeutic goal for diseases like type 1 diabetes, multiple sclerosis, and rheumatoid arthritis [1, 7].
Transplantation tolerance
Positive regulation of tolerance induction is critical for achieving transplantation tolerance, where the immune system accepts donor organs without chronic immunosuppression. DC-SIGN+ macrophages control the induction of transplantation tolerance in mouse models. Liver sinusoidal endothelial cells contribute to tolerance in liver transplants by regulating CD8 T cell responses. Strategies to boost tolerance induction are actively pursued to improve graft survival and reduce side effects of immunosuppressive drugs.
Cancer immune evasion
Tumors exploit positive regulation of tolerance induction to evade immune destruction. The co-inhibitory gene module, including PD-1 and CTLA-4, is often upregulated in tumor-infiltrating T cells, leading to exhaustion and tolerance. Checkpoint inhibitors block these pathways to restore anti-tumor immunity, but many patients do not respond, highlighting the need to understand additional tolerance mechanisms. Targeting positive regulators of tolerance induction is a major strategy in cancer immunotherapy.
Pregnancy complications
Maternal-fetal tolerance is essential for successful pregnancy, and its dysregulation can lead to recurrent miscarriage or preeclampsia. Regulatory KIR+CD8+ T cells are elevated during human pregnancy and are thought to contribute to tolerance. Understanding how positive regulation of tolerance induction operates at the maternal-fetal interface may lead to therapies for pregnancy complications.
From positive regulation of tolerance induction-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X positively regulate tolerance induction in T cells? | Knockout mouse or CRISPR knockout in primary T cells followed by tolerance assays [1, 5] |
| Does a point mutation in gene Y alter its tolerogenic function? | Point-mutation knock-in mouse or CRISPR base editing in cell lines [1, 4] |
| Can overexpression of gene Z enhance transplantation tolerance? | Transgenic overexpression mouse or lentiviral overexpression in dendritic cells |
| What is the role of gene W in thymic central tolerance? | Thymic epithelial cell-specific knockout or knock-in |
| How does retinoic acid signaling modulate tolerance induction? | RARA/RARB knockout or overexpression in dendritic cells |
| What is the impact of KIR+CD8+ T cells on maternal-fetal tolerance? | Humanized mouse models or ex vivo human pregnancy samples |
How to Study the positive regulation of tolerance induction Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Flow cytometry | Frequency and phenotype of T cell subsets, co-inhibitory receptor expression [1, 3] | Monitoring tolerance induction in transplantation and autoimmunity |
| Single-cell RNA-seq | Transcriptional heterogeneity of tolerogenic cells [1, 3] | Discovering novel regulators of tolerance |
| CRISPR knockout screen | Genes required for tolerance induction | Identifying positive regulators in T cells |
| CRISPR activation screen | Genes whose overexpression enhances tolerance | Finding targets for tolerance-promoting therapies |
| Tetramer staining | Antigen-specific T cell responses [1, 5] | Tracking tolerance to defined antigens |
| Adoptive transfer | Suppressive function of regulatory T cells [3, 7] | Testing tolerance induction in vivo |
| Immunohistochemistry | Localization of tolerogenic APCs and T cells [5, 6] | Studying tissue-specific tolerance |
| Cytokine profiling | Levels of IL-10, TGF-beta, and other mediators [7, 8] | Assessing tolerogenic milieu |
Flow cytometry and tetramer staining
Flow cytometry with peptide-MHC tetramers allows identification and quantification of antigen-specific T cells undergoing tolerance induction. This method can track the expansion of regulatory T cells and the expression of co-inhibitory receptors such as PD-1 and CTLA-4 [1, 3]. It is widely used to assess tolerance in transplantation and autoimmune models.
Transcriptomics and single-cell RNA sequencing
RNA sequencing, especially at single-cell resolution, reveals the transcriptional programs underlying positive regulation of tolerance induction. The co-inhibitory gene module was identified through transcriptomic analysis of T cells. Single-cell RNA-seq can uncover heterogeneity in tolerogenic antigen-presenting cells and regulatory T cell subsets [3, 7].
CRISPR screens
Genome-wide CRISPR knockout or activation screens can identify positive regulators of tolerance induction. For example, screens in T cells can reveal genes whose loss enhances or diminishes tolerance. These screens are powerful for discovering novel regulators and drug targets.
In vivo tolerance models
Animal models such as skin or heart transplantation, experimental autoimmune encephalomyelitis (EAE), and pregnancy models are used to study tolerance induction in vivo [3, 7]. These models allow assessment of whether a gene or pathway positively regulates tolerance and can be combined with conditional knockout or overexpression.
How CRISPR Can Be Used to Study GO:0002645 positive regulation of tolerance induction
Knockout
CRISPR knockout of candidate genes in T cells or antigen-presenting cells can determine whether they are required for positive regulation of tolerance induction. For example, knocking out Pdcd1 or Ctla4 in mice leads to autoimmunity, demonstrating their role in tolerance. Knockout of Aire in thymic epithelial cells impairs central tolerance. These models are essential for causal inference.
Point Mutation
CRISPR base editing or homology-directed repair can introduce point mutations to dissect specific domains or signaling motifs. For instance, mutating phosphorylation sites in a co-inhibitory receptor can reveal their importance for tolerance induction. Point mutations in AIRE found in APECED patients can be modeled to understand disease mechanisms.
Knock-in
Knock-in of reporter genes (e.g., GFP) or epitope tags allows tracking of tolerogenic cell populations and proteins. Knock-in of human disease variants into mouse models can reveal their impact on tolerance induction. Knock-in of Cre recombinase under a tolerogenic gene promoter enables lineage tracing.
Overexpression
CRISPR activation or transgenic overexpression can test whether increasing a gene's activity enhances tolerance induction. Overexpression of Foxp3 in conventional T cells converts them into regulatory T cells, promoting tolerance [3, 7]. Overexpression of retinoic acid receptors can enhance tolerogenic dendritic cell function.
How EDITGENE Supports positive regulation of tolerance induction Research
Researchers studying positive regulation of tolerance induction-related genes often need to determine whether a candidate gene is causally involved in promoting tolerance, and whether its manipulation can alter immune responses in disease models. EDITGENE provides comprehensive CRISPR-based services to generate knockout, point-mutation, knock-in, and overexpression cell models, as well as library screening and bioinformatics support, enabling rigorous investigation of GO:0002645 mechanisms.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of tolerance induction research.
Frequently Asked Questions About positive regulation of tolerance induction
What is GO:0002645 positive regulation of tolerance induction?
GO:0002645 is a Gene Ontology biological process term defined as any process that activates or increases the frequency, rate, or extent of tolerance induction, which is the establishment of immune non-responsiveness to antigens [1, 5, 7].
What genes are involved in positive regulation of tolerance induction?
Key genes include PDCD1 (PD-1), CTLA4, LAG3, TIGIT, FOXP3, AIRE, TGFB1, IL10, and CD209 (DC-SIGN), among others [1, 3, 4, 7, 8].
How does positive regulation of tolerance induction work?
It involves co-inhibitory signaling in T cells, tolerogenic antigen-presenting cells, thymic selection, regulatory T cell expansion, and soluble mediators like retinoic acid that collectively promote immune non-responsiveness [1, 4, 5, 7, 8].
Why is positive regulation of tolerance induction important in transplantation?
It enables the immune system to accept donor organs without chronic immunosuppression, and understanding it can lead to therapies that induce transplantation tolerance.
What diseases are linked to defects in tolerance induction?
Autoimmune diseases such as APECED, type 1 diabetes, and multiple sclerosis, as well as pregnancy complications and cancer immune evasion, are linked to dysregulated tolerance induction [1, 3, 4].
How can CRISPR be used to study positive regulation of tolerance induction?
CRISPR knockout, point mutation, knock-in, and overexpression models allow researchers to test the causal role of specific genes in tolerance induction and identify new therapeutic targets [1, 4, 7].
What are the main cell types involved in positive regulation of tolerance induction?
T cells, regulatory T cells, dendritic cells, macrophages, liver sinusoidal endothelial cells, and thymic mimetic cells are key players [1, 3, 4, 5, 7].
What is the role of retinoic acid in tolerance induction?
Retinoic acid promotes regulatory T cell differentiation and suppresses pro-inflammatory Th17 cells, thereby positively regulating tolerance induction.
How do co-inhibitory receptors regulate tolerance?
Receptors such as PD-1, CTLA-4, LAG-3, and TIGIT deliver inhibitory signals that restrain T cell activation and promote tolerance, and they are transcriptionally regulated as a module.
What experimental models are used to study positive regulation of tolerance induction?
Common models include knockout and transgenic mice, CRISPR-edited cell lines, transplantation models, EAE, and pregnancy models, combined with flow cytometry, RNA-seq, and functional assays [1, 3, 5, 7].
Conclusion
Positive regulation of tolerance induction (GO:0002645) is a vital biological process that maintains immune homeostasis and prevents autoimmunity, while also being exploited by tumors and pathogens. The integration of co-inhibitory signaling, tolerogenic antigen-presenting cells, thymic selection, and soluble mediators ensures that tolerance is actively promoted in appropriate contexts [1, 4, 5, 7, 8]. Advances in CRISPR-based gene editing and screening are accelerating the discovery of novel regulators and therapeutic targets. EDITGENE's comprehensive services empower researchers to dissect these mechanisms and translate them into clinical applications for autoimmune diseases, transplantation, and cancer immunotherapy.
References
- 1. Chihara N et al.. 2018. Induction and transcriptional regulation of the co-inhibitory gene module in T cells.. Nature 558(7710):454-459 PMID: 29899446
- 3. Li J et al.. 2025. Regulatory KIR(+)CD8(+) T cells are elevated during human pregnancy.. Sci Transl Med 17(810):eadm7697 PMID: 40768597
- 4. Givony T et al.. 2023. Thymic mimetic cells function beyond self-tolerance.. Nature 622(7981):164-172 PMID: 37674082
- 5. Schurich A et al.. 2010. Dynamic regulation of CD8 T cell tolerance induction by liver sinusoidal endothelial cells.. J Immunol 184(8):4107-14 PMID: 20212092
- 6. Streilein JW. 1997. Regulation of ocular immune responses.. Eye (Lond) 11 ( Pt 2):171-5 PMID: 9349408
- 7. Conde P et al.. 2015. DC-SIGN(+) Macrophages Control the Induction of Transplantation Tolerance.. Immunity 42(6):1143-58 PMID: 26070485
- 8. Kim CH. 2008. Roles of retinoic acid in induction of immunity and immune tolerance.. Endocr Metab Immune Disord Drug Targets 8(4):289-94 PMID: 19075782
